Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model
Abstract Alzheimer’s disease (AD) is a common neurodegenerative disease with poor prognosis. New options for drug discovery targets are needed. We developed an imaging based arrayed CRISPR method to interrogate the human genome for modulation of in vitro correlates of AD features, and used this to a...
Guardado en:
Autores principales: | Lishu Duan, Mufeng Hu, Joseph A. Tamm, Yelena Y. Grinberg, Fang Shen, Yating Chai, Hualin Xi, Lauren Gibilisco, Brinda Ravikumar, Vivek Gautam, Eric Karran, Matthew Townsend, Robert V. Talanian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e41bb5dc26104cbeac5ee6be3c197b17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
por: Mar Cuadrado-Tejedor, et al.
Publicado: (2021) -
EGCG impedes human Tau aggregation and interacts with Tau
por: Shweta Kishor Sonawane, et al.
Publicado: (2020) -
Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries
por: Emmanouil Metzakopian, et al.
Publicado: (2017) -
Programming Native CRISPR Arrays for the Generation of Targeted Immunity
por: Alexander P. Hynes, et al.
Publicado: (2016)